United States · FDA National Drug Code directory
VABYSMO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-096_d03c8813-cfdd-498f-9085-44e3d8436620
- Product NDC
- 50242-096
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Faricimab
- Labeler
- Genentech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20220128
- Source listing expiry
- 20271231
Source-listed ingredients
- FARICIMAB — 6 mg/.05mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (50242-096-01) / .05 mL in 1 VIAL (50242-096-03) · 50242-096-01
- 1 SYRINGE in 1 CARTON (50242-096-06) / .05 mL in 1 SYRINGE · 50242-096-06
- 1 SYRINGE in 1 CARTON (50242-096-45) / .05 mL in 1 SYRINGE · 50242-096-45
- 1 VIAL in 1 CARTON (50242-096-86) / .05 mL in 1 VIAL (50242-096-77) · 50242-096-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →